SCHLACKMAN SCOTT

Average Profitability
<0.0001%
Insider Buys Quantity
5
Insider Buys Sum
$10,575.35
Insider Sells Quantity
6
Insider Sells Sum
$1.63M

Insider Activity of SCHLACKMAN SCOTT

According to the SEC Form 4 filings, SCHLACKMAN SCOTT, being in a position of

  1. director at Medifast, Inc.,
    оver the last 12 months, has bought 53 shares for $3,627, and sold 4053 shares for $159,866,
    over all time since 2019-03-05, has bought 126 shares for $10,575, and sold 14872 shares for $1.63M.

The largest purchase of all time was on 2023-11-07 and amounted to 53 shares of Medifast, Inc. for $3,627.

The largest sale of all time was on 2020-06-04 and amounted to 3119 shares of Medifast, Inc. for $335,455.

Biography of SCHLACKMAN SCOTT

No biography is available at this moment.

2024-03-08SaleMedifast, Inc.
MED
director
4,053
0.0367%
$39.44$159,866-44.49%
2023-11-07PurchaseMedifast, Inc.
MED
director
52.65
0.0005%
$68.89$3,627-51.11%
2023-08-08PurchaseMedifast, Inc.
MED
director
39.82
0.0004%
$89.42$3,561-38.87%
2023-05-09PurchaseMedifast, Inc.
MED
director
13.14
0.0001%
$87.50$1,150-18.78%
2023-03-10SaleMedifast, Inc.
MED
director
2,200
0.0206%
$108.68$239,096-22.97%
2023-02-07PurchaseMedifast, Inc.
MED
director
9.8
<0.0001%
$114.97$1,127-25.31%
2022-11-08PurchaseMedifast, Inc.
MED
director
10.38
<0.0001%
$106.93$1,110-9.66%
2021-05-19SaleMedifast, Inc.
MED
director
1,000
0.0083%
$310.23$310,232-34.13%
2020-06-04SaleMedifast, Inc.
MED
director
3,119
0.0264%
$107.55$335,455+82.56%
2019-03-08SaleMedifast, Inc.
MED
director
2,000
0.0168%
$130.92$261,844-15.54%
2019-03-05SaleMedifast, Inc.
MED
director
2,500
0.0206%
$129.80$324,500-16.02%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.